ArticleNutrition & metabolism2025
Association between multimarkers of metabolic malnutrition and inflammation and risk of chronic obstructive pulmonary disease and lung function: a prospective cohort study of UK biobank.
Article in Nutrition & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Sex-Specific Plasma Metabolomic Signatures in COPD Reveal Creatine, Purine/Urate, and Bile-Acid Axes.Metabolites · 2026Article
- Metabolic vulnerability, genetic susceptibility, and incident age-related eye diseases: a prospective cohort study.Frontiers in nutrition · 2026Article
- Evidence of immune-metabolic imbalance prior to sepsis: a prospective study in the UK Biobank.Frontiers in nutrition · 2026Article
- Association of metabolic and inflammation vulnerabilities with systemic lupus erythematosus: a prospective UK Biobank study.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundChronic obstructive pulmonary disease (COPD) pathogenesis involves the cross-links between inflammation, oxidative stress, and metabolic dysregulation leading to irreversible airflow limitation. The metabolic vulnerability index (MVX) integrates inflammation and metabolic malnutrition related metabolic biomarkers that may reflect these underlying mechanisms. This study aimed to assess the associations of MVX score with risk of incident COPD and lung function in the UK Biobank.
methodsThe sex-specific MVI score was developed as a composite biomarker, which integrates six nuclear magnetic resonance (NMR)-based plasma biomarkers, including glycoprotein acetyls (GlycA), small high-density lipoprotein particles (sHDL), citrate, and the branched-chain amino acids (isoleucine, leucine, and valine). Multivariable Cox or linear regression model was used to assess the association of MVX score with risk of COPD and lung function level, respectively.
resultsA total of 240,873 participants were included. The results showed that per 1-SD increase in MVX score was associated with a 19% increased risk of COPD (HR: 1.19, 95% CI: 1.16, 1.21). Furthermore, compared to low MVX score group (Q1), high MVX score group (Q4) was associated with 55% increased risk of COPD (HR: 1.55, 95% CI: 1.45, 1.66). Furthermore, per 1-SD increase in MVX score was associated with decreased lung function level, including FVC (β: -67.55, 95% CI: -71.36, -63.74) and FEV1 (β: -52.24, 95% CI: -55.34, -49.14). Compared to low MVX score group (Q1), high MVX score group (Q4) was also associated with lower FVC (β: -174.78, 95% CI: -185.47, -164.10) and FEV1 (β: -135.72, 95% CI: -144.42, -127.02) levels. Furthermore, we observed the significant dose-response relationship between MVX score and COPD risk and lung function level.
conclusionOur study demonstrates that higher MVX score, reflecting inflammation and metabolic malnutrition, is significantly associated with increased COPD risk and impaired lung function. These findings suggest that MVX score may help identify high-risk individuals for early intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.